Determinants of age-specific undernutrition in children aged less than 2 years-the Bangladesh context

Nuzhat Choudhury1, Mohammad Jyoti Raihan1, Sabiha Sultana2

  • 1Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.

Insights

Undernutrition in children under 2 years is common in low-income countries. Maternal factors and food insecurity are key risk factors for stunting, wasting, and being underweight.

Area of Science:

  • Public Health
  • Pediatrics
  • Nutrition Science

Background:

  • Undernutrition affects nearly half of children globally, particularly in low- and middle-income countries.
  • Childhood undernutrition manifests in various forms, including stunting, wasting, and being underweight.

Purpose of the Study:

  • To identify age-specific risk factors for different undernutrition categories in Bangladeshi children under 2 years.
  • To provide evidence for targeted interventions to combat childhood undernutrition.

Main Methods:

  • Analysis of data from 10,291 children under 2 years collected via the Food Security Nutritional Surveillance Project in Bangladesh (2011-2013).
  • Utilized simple and multiple logistic regression to identify bivariate and age-specific independent risk factors for undernutrition categories.

Main Results:

  • Prevalence rates: 30.9% stunting, 9.7% wasting, 24.9% underweight.
  • Strongest predictors for all undernutrition categories included male sex, increasing age, maternal body mass index (BMI), maternal education, and household food insecurity.
  • Maternal BMI and household food insecurity emerged as common age-specific risk factors across all undernutrition categories.

Conclusions:

  • Childhood undernutrition categories possess distinct age-specific risk factors.
  • Maternal nutritional status (BMI) and household food security are critical, common risk factors for undernutrition in young children.
  • Findings can inform evidence-based strategies to reduce undernutrition in children under 2 years.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
309
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
626
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
303
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349